1. Home
  2. IMMX vs BLMN Comparison

IMMX vs BLMN Comparison

Compare IMMX & BLMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immix Biopharma Inc.

IMMX

Immix Biopharma Inc.

HOLD

Current Price

$9.76

Market Cap

629.3M

Sector

Health Care

ML Signal

HOLD

BLMN

Bloomin' Brands Inc.

HOLD

Current Price

$8.82

Market Cap

709.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMMX
BLMN
Founded
2014
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
629.3M
709.7M
IPO Year
2021
2012

Fundamental Metrics

Financial Performance
Metric
IMMX
BLMN
Price
$9.76
$8.82
Analyst Decision
Strong Buy
Hold
Analyst Count
5
8
Target Price
$19.20
$7.88
AVG Volume (30 Days)
1.5M
2.0M
Earning Date
05-08-2026
05-06-2026
Dividend Yield
N/A
4.99%
EPS Growth
N/A
106.71
EPS
N/A
0.65
Revenue
N/A
$4,213,346,000.00
Revenue This Year
N/A
$2.07
Revenue Next Year
N/A
$1.81
P/E Ratio
N/A
$13.31
Revenue Growth
N/A
N/A
52 Week Low
$1.94
$5.19
52 Week High
$11.61
$10.70

Technical Indicators

Market Signals
Indicator
IMMX
BLMN
Relative Strength Index (RSI) 59.36 65.01
Support Level $7.99 $7.03
Resistance Level $9.77 N/A
Average True Range (ATR) 0.74 0.46
MACD 0.20 0.08
Stochastic Oscillator 73.16 93.92

Price Performance

Historical Comparison
IMMX
BLMN

About IMMX Immix Biopharma Inc.

Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.

About BLMN Bloomin' Brands Inc.

Bloomin Brands Inc is a casual dining restaurant company, with a portfolio of, differentiated restaurant concepts. Its restaurant portfolio includes Outback Steakhouse, Carrabba's Italian Grill, Bonefish Grill and Fleming's Prime Steakhouse & Wine Bar. Its restaurant concepts range in price point and degree of formality from casual (Outback Steakhouse and Carrabba's Italian Grill) to polished casual (Bonefish Grill) and fine dining (Fleming's Prime Steakhouse & Wine Bar). The U.S. segment includes all restaurants operating in the U.S. while franchised restaurants operating outside the U.S. are included in the international franchise segment.

Share on Social Networks: